Invention Grant
US08916564B2 Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
有权
取代的吡啶并[1,2-a]吡嗪用于治疗神经变性和神经障碍
- Patent Title: Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
- Patent Title (中): 取代的吡啶并[1,2-a]吡嗪用于治疗神经变性和神经障碍
-
Application No.: US14031163Application Date: 2013-09-19
-
Publication No.: US08916564B2Publication Date: 2014-12-23
- Inventor: Martin Youngjin Pettersson , Douglas Scott Johnson , Chakrapani Subramanyam , Christopher John O'Donnell , Christopher William am Ende , Michael Eric Green , Nandini Chaturbhai Patel , Cory Michael Stiff , Tuan Phong Tran , Gregory Wayne Kauffman , Antonia Friederike Stepan , Patrick Robert Verhoest
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Richard V. Zanzalari
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D471/04
![Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders](/abs-image/US/2014/12/23/US08916564B2/abs.jpg.150x150.jpg)
Abstract:
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20140088111A1 Novel Bicyclic Pyridinones Public/Granted day:2014-03-27
Information query
IPC分类: